Diane Krause, MD
Clinical Pathology/Laboratory Medicine · New Haven, CTNPI 1780675199
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,240 of the $2,772 with a category attached, or 80.8%. Novo Nordisk Health Care AG accounts for 80.8% of it on its own, with 2 other manufacturers making up the rest. 2024 is the largest year on record at $1,800, 3.4 times the $532 reported in 2019.
Across 4 payments — averaging $693.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk Health Care AG$2K
- Terumo BCT, Inc.$413
- Gilead$120
Across 4 payments — averaging $95,184 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$381K
What the payments were for
- Consulting fees$2,24081%
- Speaking & faculty fees$41315%
- Food & beverage$1204%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk Health Care AG | 2 | $2,240 |
| Terumo BCT, Inc. | 1 | $413 |
| Gilead | 1 | $120 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few clinical pathology/laboratory medicine providers in Connecticutto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other clinical pathology/laboratory medicine in New Haven
- Sheldon CampbellNew Haven$13K
- Henry RinderNew Haven$6K
- Mark ShlomchikNew Haven$6K
- Wade SchulzNew Haven$5K
- Thomas DurantNew Haven$5K
- Craig WilenNew Haven$1K
- Marie LandryNew Haven$91
- Roa HarbNew Haven$29
- Brian SmithNew Haven$26
- Gualberto RuanoHartford$223
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.